Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Clinical trial NCT07336797 · RECRUITING

Trial details

NCT number: NCT07336797
Sponsor: Abdelrahman Mahmoud
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Syndrome Obesity & Overweight HIV (Human Immunodeficiency Virus)

Start date: 2025-09-01
Primary completion: 2026-12-30
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.